Abstract
Trichodysplasia spinulosa (TS) is a unique, rare clinical and histological dermatologic entity described mainly in a setting of immunosuppression. It is caused by a novel human polymoavirus, TS-associated polyomavirus. Reduction of immunosuppression and/or anti-viral therapy is the main therapeutic strategies used to treat such cases. We report a biopsy-proven case of TS in a male renal transplant patient who presented to a dermatology outpatient clinic in Montreal, Canada, in 2015. He was managed with valgancyclovir with no obvious response. Subsequently, a trial of topical imiquimod was commenced. Awareness of TS can prompt early diagnosis and management to prevent possible complications.
Keywords: Immunosuppression; Organ Transplant; Human Polyomavirus; Case Report; Canada.
Publication Date
2-28-2024
First Page
131
Last Page
134
Creative Commons License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 International License.
Recommended Citation
Khalili, Ayida Al; Maciagowski, Elsa; Nguyen, Khue; and Watters, Kevin A.
(2024)
"Trichodysplasia Spinulosa,"
Sultan Qaboos University Medical Journal: Vol. 24: 131-134.
DOI: https://doi.org/10.18295/squmj.5.2023.035
